Immunomodulation in the critically ill

Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a ‘magic bullet’...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of anaesthesia : BJA Vol. 103; no. 1; pp. 70 - 81
Main Authors Webster, N.R., Galley, H.F.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.07.2009
Oxford University Press
Oxford Publishing Limited (England)
British Journal of Anaesthesia. Published by Elsevier Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a ‘magic bullet’. Various approaches have been tried over the last 20 yr: steroids; anti-endotoxin or anti-cytokine antibodies; cytokine receptor antagonists; and other agents with immune-modulating side-effects. However, in some respects, research along these lines has been unsuccessful or disappointing at best. The current state of knowledge is summarized with particular reference to sepsis and the acute respiratory distress syndrome.
Bibliography:ark:/67375/HXZ-08KDGBND-T
istex:DD723223B1E1594F4FFD2E7A377FB7542ACC0706
ArticleID:aep128
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0007-0912
1471-6771
DOI:10.1093/bja/aep128